glp-1 agonists for type 2 diabetes receptor in the treatment of – state-of-the-art VisualAbstract: Glucagon-like peptide 1 receptor
Description
Dysregulation of inflammasomes is closely linked to numerous human diseases, including neurodegenerative diseases, cancers, and vascular diseases
Additionally, patients with constipation-predominant IBS (IBS-C) exhibit significantly lower serum GLP-1 levels, which negatively correlate with abdominal pain scores
Ltd., Japan and a grant from AstraZeneca K.K., Japan not related to the submitted work
The company describes this initial assessment as having no cost
Despite their considerable benefits, GLP-1 RAs are associated with various adverse reactions (Fig
According to a recent study, patients with the condition developed widespread maculopapular rashes, which disappeared when therapy was stopped
